Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Vitamin D and its receptor in skeletal muscle are associated with muscle disease manifestation, lipid metabolism and physical fitness of patients with myositis

L. Vernerová, M. Vokurková, NA. Laiferová, M. Nemec, M. Špiritović, O. Mytiai, S. Oreská, M. Klein, K. Kubínová, V. Horváthová, T. Kropáčková, L. Wenchich, M. Tomčík, J. Ukropec, B. Ukropcová, J. Vencovský

. 2025 ; 27 (1) : 48. [pub] 20250304

Language English Country England, Great Britain

Document type Journal Article

Grant support
NU21-05-00322 Ministry of Health of the Czech Republic
NU21-05-00322 Ministry of Health of the Czech Republic
023728 Ministry of Health of the Czech Republic
NU21-05-00322 Ministry of Health of the Czech Republic
NU21-05-00322 Ministry of Health of the Czech Republic
023728 Ministry of Health of the Czech Republic
023728 Ministry of Health of the Czech Republic
023728 Ministry of Health of the Czech Republic
023728 Ministry of Health of the Czech Republic
NU21-05-00322 Ministry of Health of the Czech Republic
NU21-05-00322 Ministry of Health of the Czech Republic
NU21-05-00322 Ministry of Health of the Czech Republic
NU21-05-00322 Ministry of Health of the Czech Republic
LM2023033 Large research infrastructure project BBMRI.cz
LM2023033 Large research infrastructure project BBMRI.cz
LM2023033 Large research infrastructure project BBMRI.cz
LM2023033 Large research infrastructure project BBMRI.cz
APVV 20/0466 The Ministry of Education, Research, Development and Youth of the Slovak Republic
APVV 20/0466 The Ministry of Education, Research, Development and Youth of the Slovak Republic
APVV 20/0466 The Ministry of Education, Research, Development and Youth of the Slovak Republic
APVV 20/0466 The Ministry of Education, Research, Development and Youth of the Slovak Republic
APVV 20/0466 The Ministry of Education, Research, Development and Youth of the Slovak Republic
SVV 260638 Ministry of Education Youth and Sports of the Czech Republic
SVV 260638 Ministry of Education Youth and Sports of the Czech Republic
SVV 260638 Ministry of Education Youth and Sports of the Czech Republic

BACKGROUND: Low levels of vitamin D have been associated with several autoimmune diseases. A growing body of evidence supports the association of vitamin D with skeletal muscle damage, regeneration, and energy and lipid metabolism. The aim was to analyse vitamin D and its receptor (VDR) in the muscle tissue of patients with idiopathic inflammatory myopathies (IIM) and to relate them to clinical parameters and muscle lipid and energy metabolism. METHODS: Forty-six patients with IIM and 67 healthy controls (HC) were included in the study. 27 IIM patients participated in a 24-week exercise intervention. Muscle biopsies were obtained from 7 IIM patients before/after training, 13 non-exercising IIM controls, and 21 HC. Circulating concentrations of 25(OH)D and 1,25(OH)D were measured. Gene expression of VDR and CYP27B1, the enzyme converting 25(OH)D to hormonally active 1,25(OH)D, was determined by qPCR in muscle tissue and primary muscle cells. Lipid oxidative metabolism was assessed in muscle tissue (mRNA, qPCR) and primary muscle cells (radioactive assays). RESULTS: Lower levels of active 1,25(OH)D were observed in IIM patients compared with HC (mean ± SD: 125.0 ± 45.4 vs. 164.7 ± 49.2 pmol/L; p < 0.0001). 25(OH)D was associated with CRP (r = -0.316, p = 0.037), MITAX (r = -0.311, p = 0.040) and HAQ (r = -0.390, p = 0.009) in IIM. After 24 weeks of training, active 1,25(OH)D was associated with MMT8 (r = 0.866, p < 0.0001), FI-2 (r = 0.608, p = 0.013) and HAQ (r = -0.537, p = 0.032). Gene expression of both VDR and CYP27B1 in primary muscle cells decreased after training (p = 0.031 and p = 0.078, respectively). Associations of VDR mRNA in muscle tissue with MMT-8 (IIM: r = -0.559, p = 0.013), serum CK (HC: r = 0.484, p = 0.031), myoglobin (IIM: r = 0.510, p = 0.026) and myostatin (IIM: r = -0.519, p = 0.023) were observed. The expression of VDR in differentiated muscle cells correlated negatively with the complete oxidation of palmitic acid (r = -0.532, p = 0.028). Muscle mRNA of carnitine palmitoyl transferase 1 (CPT1) (downregulated in IIM, p = 0.001) correlated positively with serum 1,25(OH) vitamin D (r = 0.410, p = 0.042). CONCLUSION: Reduced biologically active vitamin D in circulation suggests its impaired metabolism in IIM. Serum vitamin D levels and gene expression of its receptor and activating enzyme in muscle tissue were modified by regular exercise and associated with disease manifestations, physical fitness, and muscle lipid metabolism of IIM patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009567
003      
CZ-PrNML
005      
20250429134936.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13075-025-03516-9 $2 doi
035    __
$a (PubMed)40038731
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Vernerová, Lucia $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic
245    10
$a Vitamin D and its receptor in skeletal muscle are associated with muscle disease manifestation, lipid metabolism and physical fitness of patients with myositis / $c L. Vernerová, M. Vokurková, NA. Laiferová, M. Nemec, M. Špiritović, O. Mytiai, S. Oreská, M. Klein, K. Kubínová, V. Horváthová, T. Kropáčková, L. Wenchich, M. Tomčík, J. Ukropec, B. Ukropcová, J. Vencovský
520    9_
$a BACKGROUND: Low levels of vitamin D have been associated with several autoimmune diseases. A growing body of evidence supports the association of vitamin D with skeletal muscle damage, regeneration, and energy and lipid metabolism. The aim was to analyse vitamin D and its receptor (VDR) in the muscle tissue of patients with idiopathic inflammatory myopathies (IIM) and to relate them to clinical parameters and muscle lipid and energy metabolism. METHODS: Forty-six patients with IIM and 67 healthy controls (HC) were included in the study. 27 IIM patients participated in a 24-week exercise intervention. Muscle biopsies were obtained from 7 IIM patients before/after training, 13 non-exercising IIM controls, and 21 HC. Circulating concentrations of 25(OH)D and 1,25(OH)D were measured. Gene expression of VDR and CYP27B1, the enzyme converting 25(OH)D to hormonally active 1,25(OH)D, was determined by qPCR in muscle tissue and primary muscle cells. Lipid oxidative metabolism was assessed in muscle tissue (mRNA, qPCR) and primary muscle cells (radioactive assays). RESULTS: Lower levels of active 1,25(OH)D were observed in IIM patients compared with HC (mean ± SD: 125.0 ± 45.4 vs. 164.7 ± 49.2 pmol/L; p < 0.0001). 25(OH)D was associated with CRP (r = -0.316, p = 0.037), MITAX (r = -0.311, p = 0.040) and HAQ (r = -0.390, p = 0.009) in IIM. After 24 weeks of training, active 1,25(OH)D was associated with MMT8 (r = 0.866, p < 0.0001), FI-2 (r = 0.608, p = 0.013) and HAQ (r = -0.537, p = 0.032). Gene expression of both VDR and CYP27B1 in primary muscle cells decreased after training (p = 0.031 and p = 0.078, respectively). Associations of VDR mRNA in muscle tissue with MMT-8 (IIM: r = -0.559, p = 0.013), serum CK (HC: r = 0.484, p = 0.031), myoglobin (IIM: r = 0.510, p = 0.026) and myostatin (IIM: r = -0.519, p = 0.023) were observed. The expression of VDR in differentiated muscle cells correlated negatively with the complete oxidation of palmitic acid (r = -0.532, p = 0.028). Muscle mRNA of carnitine palmitoyl transferase 1 (CPT1) (downregulated in IIM, p = 0.001) correlated positively with serum 1,25(OH) vitamin D (r = 0.410, p = 0.042). CONCLUSION: Reduced biologically active vitamin D in circulation suggests its impaired metabolism in IIM. Serum vitamin D levels and gene expression of its receptor and activating enzyme in muscle tissue were modified by regular exercise and associated with disease manifestations, physical fitness, and muscle lipid metabolism of IIM patients.
650    _2
$a lidé $7 D006801
650    12
$a receptory kalcitriolu $x metabolismus $7 D018167
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a kosterní svaly $x metabolismus $7 D018482
650    12
$a metabolismus lipidů $x fyziologie $7 D050356
650    12
$a vitamin D $x krev $x metabolismus $7 D014807
650    _2
$a lidé středního věku $7 D008875
650    12
$a myozitida $x metabolismus $7 D009220
650    _2
$a dospělí $7 D000328
650    12
$a tělesná výkonnost $x fyziologie $7 D010809
650    _2
$a 1-alfa-hydroxylasa 25-hydroxyvitaminu D3 $x metabolismus $7 D015090
650    _2
$a senioři $7 D000368
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vokurková, Martina $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic
700    1_
$a Laiferová, Nikoleta Alchus $u Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
700    1_
$a Nemec, Michal $u Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
700    1_
$a Špiritović, Maja $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic $u Department of Health Care Disciplines and Population, Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic
700    1_
$a Mytiai, Oksana $u Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia $u Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Oreská, Sabína $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Klein, Martin $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kubínová, Kateřina $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Horváthová, Veronika $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Kropáčková, Tereza $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Wenchich, László $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic
700    1_
$a Tomčík, Michal $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Ukropec, Jozef $u Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
700    1_
$a Ukropcová, Barbara $u Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia $u Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Vencovský, Jiří $u Institute of Rheumatology, Na Slupi 4, Prague, 12850, Czech Republic. vencovsky@revma.cz $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic. vencovsky@revma.cz
773    0_
$w MED00007534 $t Arthritis research & therapy $x 1478-6362 $g Roč. 27, č. 1 (2025), s. 48
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40038731 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134931 $b ABA008
999    __
$a ok $b bmc $g 2311135 $s 1246648
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 27 $c 1 $d 48 $e 20250304 $i 1478-6362 $m Arthritis research & therapy $n Arthritis Res Ther $x MED00007534
GRA    __
$a NU21-05-00322 $p Ministry of Health of the Czech Republic
GRA    __
$a NU21-05-00322 $p Ministry of Health of the Czech Republic
GRA    __
$a 023728 $p Ministry of Health of the Czech Republic
GRA    __
$a NU21-05-00322 $p Ministry of Health of the Czech Republic
GRA    __
$a NU21-05-00322 $p Ministry of Health of the Czech Republic
GRA    __
$a 023728 $p Ministry of Health of the Czech Republic
GRA    __
$a 023728 $p Ministry of Health of the Czech Republic
GRA    __
$a 023728 $p Ministry of Health of the Czech Republic
GRA    __
$a 023728 $p Ministry of Health of the Czech Republic
GRA    __
$a NU21-05-00322 $p Ministry of Health of the Czech Republic
GRA    __
$a NU21-05-00322 $p Ministry of Health of the Czech Republic
GRA    __
$a NU21-05-00322 $p Ministry of Health of the Czech Republic
GRA    __
$a NU21-05-00322 $p Ministry of Health of the Czech Republic
GRA    __
$a LM2023033 $p Large research infrastructure project BBMRI.cz
GRA    __
$a LM2023033 $p Large research infrastructure project BBMRI.cz
GRA    __
$a LM2023033 $p Large research infrastructure project BBMRI.cz
GRA    __
$a LM2023033 $p Large research infrastructure project BBMRI.cz
GRA    __
$a APVV 20/0466 $p The Ministry of Education, Research, Development and Youth of the Slovak Republic
GRA    __
$a APVV 20/0466 $p The Ministry of Education, Research, Development and Youth of the Slovak Republic
GRA    __
$a APVV 20/0466 $p The Ministry of Education, Research, Development and Youth of the Slovak Republic
GRA    __
$a APVV 20/0466 $p The Ministry of Education, Research, Development and Youth of the Slovak Republic
GRA    __
$a APVV 20/0466 $p The Ministry of Education, Research, Development and Youth of the Slovak Republic
GRA    __
$a SVV 260638 $p Ministry of Education Youth and Sports of the Czech Republic
GRA    __
$a SVV 260638 $p Ministry of Education Youth and Sports of the Czech Republic
GRA    __
$a SVV 260638 $p Ministry of Education Youth and Sports of the Czech Republic
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...